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Abstract.
Background: Spinal cord injury (SCI) is a debilitating condition characterized by a complex of neurological dysfunctions
ranging from loss of sensation to partial or complete limb paralysis. Recently, we reported that intravenous administration
of neural precursors physiologically releasing erythropoietin (namely Er-NPCs) enhances functional recovery in animals
following contusive spinal cord injury through the counteraction of secondary degeneration. Er-NPCs reached and accumu-
lated at the lesion edges, where they survived throughout the prolonged period of observation and differentiated mostly into
cholinergic neuron-like cells.
Objective: The aim of this study was to investigate the potential reparative and regenerative properties of Er-NPCs in a
mouse experimental model of traumatic spinal cord injury.
Methods and Results: We report that Er-NPCs favoured the preservation of axonal myelin and strongly promoted the
regrowth across the lesion site of monoaminergic and chatecolaminergic fibers that reached the distal portions of the injured
cord. The use of an anterograde tracer transported by the regenerating axons allowed us to assess the extent of such a process.
We show that axonal fluoro-ruby labelling was practically absent in saline-treated mice, while it resulted very significant in
Er-NPCs transplanted animals.
Conclusion:Our study shows that Er-NPCs promoted recovery of function after spinal cord injury, and that this is accompanied
by preservation of myelination and strong re-innervation of the distal cord. Thus, regenerated axons may have contributed to
the enhanced recovery of function after SCI.
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1. Introduction
Spinal cord injury (SCI) is most commonly caused
by high-energy trauma and represents a complex
emergency issue that leads most often to a chronic
condition. The majority of patients are men of 16–30
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years of age, thus in addition to the enormous per-
sonal suffering, SCI results also in substantial costs
to society (Fehlings et al., 2011; Schlayer et al.,
1988). There is currently no curative therapy, the care
in the acute phase used to be limited to high-dose
corticosteroid treatment that is now being advised
against, and surgical stabilization and decompres-
sion to possibly attenuate further damage (Fehlings
et al., 2011; Furlan et al., 2011). Numerous reports
have described the presence of inhibiting factors
in the lesion environment that limit neural regen-
eration in adult CNS and in particular across the
injury site in SCI. A variety of inhibitory molecules
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associated with myelin and extracellular matrix have
been described (Fawcett, 2006; Fitch et al., 2008; He
& Koprivca, 2004). The limiting environmental fac-
tors may include also the insufficient local presence of
growth-permissive matrices and growth factors. The
neutralization of such growth inhibitory molecules
have been extensively studied (Young, 2014) and also
a variety of stem cells or stem cell-derived molecules
as well have shown beneficial effects to a variable
extent (Martino & Pluchino, 2006; Romanko et al.,
2007). We had shown that intravenous administration
of erythropoietin-releasing adult neural precursors
cells, isolated from SVZ six hours after donor death
(Er-NPCs; formerly called post mortem-neural pre-
cursor cells; PM-NPCs; Marfia et al., 2011), improve
hind limb functional recovery. Er-NPCs accumulate
at the lesion site, where they differentiate mostly into
cholinergic neuron cells, favouring preservation of
myelin (Carelli et al., 2014a; Carelli et al., 2014b;
Carelli et al., 2015). Acute traumatic SCI is followed
by vascular changes with loss of neurons, oligoden-
droglia, and astrocytes, neuroinflammation quickly
follows with consequent invasion of the injury by
a variety of inflammatory cells. These acute condi-
tion is then associated to Wallerian degeneration of
ascending and descending tracts with gradual for-
mation of cavities in the cord, the formation of
the glial scar reduces greatly the growth ability by
axons across the injury (Gorio et al 2002, Ahuja
et al. 2017). The aim of this work was to investi-
gate the ability of Er-NPCs in axonal regeneration
across injury. Here, we show, that Er-NPCs adminis-
tration enhances restauration of TH and 5-HT positive
fibres in the caudal cord, and increases significantly
the number of axons able to cross the injury site.
This enhanced re-innervation of the caudal cord may
underlay the gradual and continuous improvement in
hind limb function that has been observed even at 90
days after lesioning.
2. Materials and methods
2.1. Animal care
In this study, adult CD1 male mice 25–30 g in
weight (Charles River, Calco, Italy) were used. All
of the procedures were approved by the Review
Committee of the University of Milan and met
the Italian Guidelines for Laboratory Animals,
which conform to the European Communities Direc-
tive (2010/63/UE). Animals were kept for at least
3 days before the experiments in standard conditions
(22 ± 2◦C, 65% humidity, and artificial light between
8:00 a.m. to 8:00 p.m.).
2.2. Er-NPCs isolation, characterization, and
labelling
Er-NPCs were obtained from 6 weeks old CD-1
albino mice; their isolation, growth and characteriza-
tion were performed by following methods described
in previously published papers (Marfia et al., 2011;
Carelli et al., 2014a; Carelli et al., 2014b; Carelli
et al., 2015) and set up in the past by Gritti and
co-workers (Gritti et al., 2002). Briefly, cells were
isolated from the SVZ 6 hours after sacrifice by
cervical dislocation. Brains were removed, and tis-
sues containing the SVZ region were dissected,
transferred to Earl’s balanced salt solution (Life Tech-
nologies, Monza, Italy) containing 1 mg/ml papain
(27 U/mg; Sigma-Aldrich, Milan, Italy), 0.2 mg/ml
cysteine (Sigma-Aldrich), and 0.2 mg/ml EDTA
(Sigma-Aldrich). Tissue was incubated for 45 min
at 37◦C on a rocking platform. Tissues were then
transferred to DMEM-F12 medium (Euroclone, Pero,
Milan, Italy) and mechanically dissociated with a
Pasteur pipette. Cells were counted and plated at
3500 cells/cm2 in DMEM-F-12 (Euroclone, Pero,
Milan, Italy) containing 2 ml-glutamine (Euroclone),
0.6% glucose (Sigma-Aldrich), 9.6 gm/ml putrescine
(Sigma-Aldrich), 6.3 ng/ml progesterone (Sigma-
Aldrich), 5.2 ng/ml sodium selenite (Sigma-Aldrich),
0.025 mg/ml insulin (Sigma-Aldrich), 0.1 mg/ml
transferrin (Sigma-Aldrich), and 2g/ml heparin
(sodium salt, grade II; Sigma-Aldrich), bFGF (human
recombinant, 10 ng/mL; Life Technologies) and
EGF (human recombinant, 20 ng/mL; Life Tech-
nologies). Spheres formed after 5–7days were
harvested, collected by centrifugation (10 min at
123 g), mechanically dissociated to a single-cell sus-
pension, and re-plated in the medium indicated above
(Marfia et al., 2011; Gritti et al., 2002; Bottai et al.,
2008). As previously described, Er-NPCs differenti-
ation was performed by plating the dissociated stem
cells at the density of 40,000 cells/cm2 in presence
of adhesion molecules (Matrigel™, BD Biosciences,
Buccinasco, MI, Italy) and bFGF (10 ng/ml) for 48
hours. After this time, the medium was changed
and cells were exposed to the same medium con-
taining foetal bovine serum (1% vol/vol; Euroclone)
and depleted of bFGF. This incubation lasted for
the following 5 days (Marfia et al. 2011; Carelli
et al. 2014b, Carelli et al. 2015). Then, the extent of
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differentiation was investigated by immunocyto-
chemical staining (Marfia et al., 2011). To monitor
the fate of Er-NPCs after transplantation PKH26 and
H33342 were used (Sigma-Aldrich). PKH26 is a non
toxic cell dye characterized by a long aliphatic tails
(PKH26) that allow the dye incorporation in lipid
regions of the cell membrane (Horan et al., 1990; Wal-
lace et al., 2008). Er-NPCs were labelled just before
the injection, following manufacturer’s instructions
and as described previously (Carelli et al., 2014a; Liu
et al., 2014).
Er-NPCs were stained with Hoechst 33342
(Sigma-Aldrich, Steinheim, Germany) at not toxic
concentration (0.5 g/mL). Floating mechanically
dissociated NPCs were incubated with H33342 solu-
tion at the final concentration of 0.5g/ml for 90
minutes at 37◦C in an incubator. After staining, the
cells were pelleted by centrifugation (500 × g for
5 min) and rinsed twice with HBSS (10 ml) (Carelli
et al., 2014a). For transplantation labelled cells were
resuspended in sterile physiologic solution at a con-
centration of 3.3 × 105 cells/50l (Carelli et al.,
2014a; Carelli et al., 2015).
2.3. Setting of experimental groups and cell
administration
Experimental animals were divided into three
groups: 1) Laminectomies mice (n = 6); 2) Lesioned
mice treated with phosphate buffer (PBS, n = 15); 3)
Lesioned mice transplanted with Er-NPCs (n = 15).
The traumatic SCI was performed using an Infinite
Horizon (IH; Precision Systems and Instrumenta-
tion, LLC, Lexington, KY, USA) device (Carelli
et al., 2014a; Gorio et al., 2007) at the T8 level.
Surgery on the animals was performed as previously
described (Carelli et al., 2014a; Carelli et al., 2014b;
Carelli et al., 2015; Gorio et al., 2007). Er-NPCs were
administered after spinal cord lesion and intravenous
administration (i.v.) was performed by tail vein injec-
tion. As previously described, the treatment includes
three different i.v. injection of 50l in volume, the
first administration 30 min after injury, followed by
a second injection 6 h later and a third one 18 h after
the lesion (Carelli et al., 2014a; Carelli et al., 2014b;
Carelli et al., 2015).
2.4. Behavioural tests and hind limb function
As described by Basso and co-workers (Basso
et al., 2006) functional recovery evaluations were
assessed in a blinded fashion. Neurological function
was evaluated first 24 h after injury and then twice a
week for the first 4 weeks. The methods utilized are
well known in the field of behavioural evaluation of
recovery of function after SCI (Basso et al., 2006).
For behavioural experiments we used 12 animals for
all experimental groups. Allodynia-like responses in
the unaffected forepaw were assessed by means of
standard hotplate test and cold stimulation as previ-
ously reported (Carelli et al., 2014b; Carelli et al.,
2015; Hofstetter et al., 2005).
2.5. Histology and immunohistochemistry
At the end of the experimental period, animals were
anesthetized and perfused as described previously
[11–13]. Spinal cords were post-fixed overnight,
cryoprotected with 30% sucrose (Sigma-Aldrich),
quickly frozen, stored at –80◦C and sectioned by
means of a cryostat (Leica) (Carelli et al. 2014a;
Carelli et al., 2014b; Carelli et al., 2015). Cryostat
sections (15m) were collected onto glass slides
and processed for immunohistochemistry. Sections
were rinsed with PBS (Euroclone), treated with
blocking solution (Life-Technologies) and incubated
with primary antibodies overnight at 4◦C. After
treatment with primary antibodies, the sections were
washed with PBS and incubated with appropriate
secondary antibodies (Alexa Fluor® 488, Molecular
Probes®, Life Technologies) for 2 hours at room
temperature. Sections were washed in PBS, nuclei
were stained with DAPI (1g/ml final concentration,
10 minutes at room temperature; Sigma-Aldrich)
and then mounted using the FluorSave Reagent
(Calbiochem, Merck Chemical, Darmstadt, Ger-
many) and analyzed by confocal microscopy. In
control determinations, primary antibodies were
omitted and replaced with equivalent concentrations
of unrelated IgG of the same subclass. The follow-
ing primary antibodies were used:, -Tubulin III
(1:150; Covance). Microtubule-Associated Protein 2
(MAP-2; 1:300; Chemicon), Tyrosine hydroxylase
(TH; 1:500; Millipore), Choline Acetyltransferase
(ChAT; 1:1000; Chemicon), 5-hydroxytryptamine
(5-HT; 1:200 Millipore); GAP-43 (1:1000;
Millipore).
2.6. Assessment of myelin preservation
Assessment of myelin preservation was evaluated
on cord sections of non- lesioned (healthy), lesioned
+ PBS and lesioned + Er-NPCs animals placed on
the same coverslip as described previously (Pertici
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et al., 2013; Carelli et al., 2014b; Carelli et al.,
2015). This approach allows for the homogeneous
evaluation of quantitative data obtained by confocal
analysis. Myelin preservation was evaluated compar-
ing the levels of myelin in the ventral white matter at
0.4 mm (rostral and caudal) laterally from the lesion
epicenter in healthy, saline and cells treated ani-
mals. The choice of the ventral white matter was
based on the knowledge that the reticular spinal
pathway descends mostly in the ipsilateral dorso-
and ventrolateral funiculi and is directly involved
in the regulation of the movement of the mouse
foot (Vitellaro-Zuccarello et al., 2007). The confo-
cal microscope images for the laminectomies animals
and saline and cells-treated mice were obtained using
the same intensity, pinhole, wavelength and thickness
of the acquisition. As reference, we used sections
close to the ones analyzed and not treated with fluo-
romyelin (Pertici et al., 2013; Carelli et al., 2014b;
Carelli et al., 2015). Briefly, the procedure of the
staining was carried out by incubating the cryosec-
tions with fluoromyelin diluted 1:300 in PBS for
20 minutes; slides were then washed three times
for 10 min each with PBS and mounted with Fluor-
Save (Merck, Darmstadt, Germany), and qualitatively
and quantitatively analyzed by confocal microscopy
(Leica TSC2; Leica Microsystems, Heidelberg,
Germany).
2.7. Fluoro-Ruby Protocol
Fluororuby is a fluorescent rhodamine-conjugated
dextran, which has been used to study in vivo axonal
transport within the central nervous system (Lu et al.,
2001). A 10% solution of Fluororuby is made by dis-
solving 10 mg of dry powder in 100L of PBS, that
was delivered via intraspinal injection at T6/T7 using
a 5L Hamilton microsyringe. Injection volumes
typically ranged from 0.5–1L and were gradually
injected over a 10–15 minute interval (Schofield et
al., 2007). The animals were then allowed to recover.
The animals were perfused 5 days after the tracer
injection with neutral buffered formaldehyde (10%
formalin in 0.1 M neutral phosphate buffer). The
spinal cord was then removed, and post-fixed for
at least overnight in the same fixative solution and
included in paraffin. The cords were then sectioned
by means of a microtome (Zeiss) with thickness set
at 10 microns. This analysis was performed on 3 ani-
mals per experimental group: (i) injected with saline
solution as a control and (ii) Er-NPCs-transplanted
animals.
2.8. Semiquantitative method of analysis for the
determination of serotoninergic and
catecholaminergic ﬁber density
Data were collected from sections taken at the
same distance (2 mm) from the lesion epicenter and
immunostained in a single batch to minimize vari-
ability. Images were acquired using standardized
confocal microscopy (Hawthorne et al., 2011; Shigyo
et al., 2016). Five consecutive sections (10m thick)
were averaged, and the count was serially repeated
every 50m for the length of 500m. Semiquanti-
tative analysis of immunoreactivity was performed
by using confocal microscopy (Leica SP2 confocal
microscope with He/Kr and Ar lasers; Heidelberg,
Germany) to evaluate the mean relative optical den-
sity. Quantification of serotonin (5-HT) and tyrosin
hydroxilase (TH) immunoreactivity was carried out
in the regions reported in Figs. 4 and 5 following the
procedure described for myelin assessment.
2.9. Statistical analysis
Data were expressed as the mean ± S.D. Multiple
groups comparison were made by ANOVA followed
by Bonferroni’s multiple comparisons test to assess
statistical significance versus respective control. The
analyses were performed using Prism 3.0 software
(GraphPad Software, Inc.). Statistical significance
was accepted for a P < 0.05.
3. Results
3.1. Er-NPCs elicit neuronal markers expression
in recipient spinal cord
Transplanted Er-NPCs localize at the edges of
injury site and show a well-structured morphology
with dendrite-like processes; they are mostly positive
for Choline-AcetylTransferase (ChAT) (Carelli et al.,
2015 and Fig. 1). The quantification performed 30
days after transplantation shows that 75 ± 5.35 per-
cent of transplanted Er-NPCs (PKH26 positive cells)
are positive for ChAT, with a dotted (Fig. 1) distri-
bution that in most cases is perinuclear, with positive
labeling of processes in several instances (Fig. 1).
The high majority of Er-NPCs localized at the bound-
aries of lesion site are also positive for MAP-2 and
-tubulin III (Fig. 2). As reported in our previous
work also in this new set of experiments none of
engrafted Er-NPCs resulted positive to GFAP or
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Fig. 1. Er-NPCs transplanted cells differentiate into cholinergic
neurons. At 30 days after i.v. injection, several PKH26-labeled
Er-NPCs (red) were accumulated at the edges of the lesion. Most
Er-NPCs were positive for ChAT immunostaining (green; stars)
(Scale bar = 50m).
oligodendrocyte markers (Carelli et al., 2015). The
quantification of MAP-2 and -tubulin III labelling
in the cord of treated animals had been performed in
sections taken both at lesion site and distally (2 mm
rostral and caudal, respectively; schematic in Fig. 2).
The presence of transplanted Er-NPCs enhances tis-
sue expression of these typical neuronal markers at
the lesion site and the rostral and caudal peripheries
(Fig. 2).
The evaluation of hind limb function recovery per-
formed by open field locomotion test is reported
in Fig. 3. The experimental animals, tested the day
prior to the injury, scored the maximum (9 points)
in the BMS scale. The 70 Kdyne traumatic impact
to the mouse cord causes a transient loss of locomo-
tion ability, that is followed by a progressive gradual
recovery reaching the maximum extent within 2-3
weeks (3.0 ± 0.450 points of the BMS scale; n = 6,
Fig. 3) (Carelli et al., 2014a; Carelli et al., 2014b;
Carelli et al., 2015). This score corresponds to plan-
tar placing of the paw with or without weight support
(Basso et al., 2006). When Er-NPCs were infused
by i.v. injection (Carelli et al., 2014a) the outcome
improved and reached a BMS score of 5.0 ± 0.50 at
day 30 (n = 6) (Basso et al., 2006). This corresponds to
frequent or consistent plantar stepping without coor-
dination, or frequent or consistent plantar stepping
with some coordination (Basso et al., 2006; Carelli
et al., 2014a; Carelli et al., 2014b; Carelli et al., 2015).
The cell-mediated improvement is particularly evi-
dent during the first 3 weeks after SCI, and then the
recovery improved steadily up to 90 days of obser-
vation (Tables 1 and 2). Two cords of treated mice at
12 weeks after Er-NPCs administration were serially
sectioned and the number of PKH26 or Hoechst –
positive cells per cord was quantified as previously
described (Carelli et al., 2015). The total number of
positive cells was 22,31 × 105 ± 6,7 × 105 per cord
at 12 weeks after transplantation. This is in complete
accordance with previously reported data (Carelli et
al., 2015), and the estimate was 10 fold higher than
survival of regular adult NSCs (Bottai et al., 2008).
3.2. Monoaminergic ﬁbers in the injured cord
Serotonin (5-HT) innervation of the cord is
involved in the regulation of the central pattern gen-
erator and the facilitation of locomotion (Lemon,
2008; Liu et al., 2009; Han et al., 2015) thus 5-HT
immunoreactivity was investigated in the injured cord
of untreated or Er-NPCs treated animals. Positive 5-
HT staining was detected in the lesion center and in
regions 2 mm rostral and caudal to the lesion cen-
ter (Fig. 4). Representative 5-HT immunoreactivity
is shown in the lesion epicenter, in its boundaries
(Fig. 4 panel A), and distally (2 mm rostral or cau-
dal to the lesion site; Fig. 4 panel B). 5-HT positive
fibers (green) form a reach network also caudally to
the lesion site in Er-NPCs-treated animals. The quan-
tification performed at 10 and 30 days after lesioning
in the caudal cord, shows that the loss of 5-HT fibers
is 60–70%; this remains unchanged at 10 days after
transplantation (Fig. 4 panel C). However, later at 30
days, 5-HT fibers are markedly more abundant both
in the ventral horns and in the intermediolateral area
(Fig. 4 panel C). A similar outcome has been observed
with TH-positive fiber; a sharp decrease is followed
by a significant recovery of TH-positive fibers inner-
vation in the caudal cord (Fig. 5 panels B and C). In
saline-treated mice, there is no recovery of 5-HT and
TH positive fibers (Figs. 4 and 5). These data suggest
that transplanted Er-NPCs have favored the recov-
ery of 5-HT and catecholaminergic fiber tracts of the
lesioned cord even in the caudal region and across the
lesion site.
3.3. Myelin preservation
The reticulospinal tract is an important pathway for
the control of locomotion through the coordination of
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Fig. 2. Er-NPCs transplantation improves neural markers expression in injured spinal cord. Pictures represent confocal acquisitions of
coronal sections taken at the edges of the lesion at 30 days after i.v. administration of PKH26 – labeled Er-NPCs (showed in red) (panel
A). Sections were immunostained for  tubulin III and MAP-2 (showed in green). PKH26-labeled cells were positive for -tubulin III and
MAP-2 (white stars) (Scale bar = 75 and 100m) (panel A). Graphs reported in panel B show the quantification of immunoreactivity in
sections taken at the lesion epicenter, 2 mm rostral or caudal to the lesion epicenter (please see schematic representation). Values represent
average ± SD. We determined the statistical differences by means of ANOVA test followed by Bonferroni’s post-test. ***p < 0.001 vs LAM;
$$p < 0.01 vs PBS.
rhythmic stepping movements (Ballerman & Fouad,
2006). It runs in the ipsilateral dorso- and ventro-
lateral funiculi of the cord, and is predominantly
constituted by myelinated axons (Loy et al., 2002).
The extent of myelination of these pathways depends
marginally on the presence of serotonergic axons
in these bundles since they are scarcely myelinated
(Loy et al., 2002; Hildebrand & Hahn, 1978). The
condition of myelin in these descending structures
was determined by evaluation of FluoroMyelin™
staining by means of confocal quantitative analysis
as detailed in Materials and Methods. Myelin was
quantified 30 days after lesion; sections were taken
at the center of the lesion and 2 mm caudally to the
lesion site (Fig. 6). Only intact myelin was assessed,
and the degenerated crumbled labeled parts were not
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Fig. 3. Mice locomotor activity evaluation after i.v. Er-NPCs infu-
sion. The evaluation of motor function recovery of hind limb was
determined by the open field locomotion test (Basso et al., 2006).
During the observation, performed in double blind fashion, ani-
mals from the different groups were randomized. Values represent
average ± SD. We determined the statistical differences by means
of two way ANOVA test followed by Bonferroni’s post-test.
Table 1
Mice locomotor activity evaluation after i.v. Er-NPCs injection.
Functional recovery of hind limb was determined by the open field
locomotion test (Basso et al., 2006; see Materials and Methods
for details). Values represent average ± SD. We determined the
statistical differences by means of two way ANOVA test followed
by Bonferroni’s post-test
Days LAM PBS Er-NPCs
–1 9.0 ± 0 9.0 ± 0 9.0 ± 0
1 8.0 ± 0.05 0.0 ± 0.87 0.0 ± 0.10
6 8.5 ± 0.05 2.0 ± 0.230 3.0 ± 0.20
(p < 0.01 vs PBS)
13 8.5 ± 0.13 2.5 ± 0.140 3.5 ± 0.30
(p < 0.001 vs PBS)
18 9.0 ± 0.06 2.5 ± 0.130 4.0 ± 0.30
(p < 0.001 vs PBS)
24 9.0 ± 0.06 3.0 ± 0.220 4.5 ± 0.45
(p < 0.001 vs PBS)
30 9.0 ± 0.06 3.0 ± 0.170 5.0 ± 0.35
(p < 0.001 vs PBS)
90 9.0 ± 0.06 3.0 ± 0.280 5.5 ± 0.45
(p < 0.001 vs PBS)
considered. The loss of myelin was evident at lesion
site and caudally, the transplanted Er-NPCs markedly
improved the extent of myelination at all analyzed
sites (Table 3).
Growth-associated protein 43 (GAP43) is
expressed at higher levels in neuronal growth cones
during development, during axonal regeneration and
it is an accepted marker of neurite outgrowth (Meiri
et al., 1986; Skene et al., 1986; Verkade et al., 1996).
To corroborate the above-described evidences on
Er-NPCs mediated re-growth of monoaminergic
pathways, spinal cord cryostat sections, taken at
2 mm from lesion epicenter, were examined for GAP-
43 expression at 30 days after cells administration
Table 2
Prospective analysis (time) of functional recovery promoted by Er-
NPCs. Hind limb functional recovery of function was evaluated by
the open field locomotion test (Basso et al., 2006; see Materials and
Methods for details). Values represent average ± SD. Statistical
significance was determined by applying two way ANOVA test
followed by Bonferroni’s post-test
Days post Behaviour P value
Er-NPCs infusion (BMS scale)
1 0.0 ± 0.10
6 3.0 ± 0.20 p < 0.001 vs day 1
13 3.5 ± 0.30 p < 0.001 vs day 1
p = n.s. vs day 6
30 5.0 ± 0.35 p < 0.001 vs day 1
p < 0.001 vs day 6
p < 0.01 vs day 13
90 5.5 ± 0.45 p < 0.001 vs day 1
p < 0.001 vs day 6
p < 0.01 vs day 13
p = n.s. vs day 30
(Fig. 7). The immunoreactivity for GAP-43 was
especially noticeable in bundles positive to -tubulin
III and in proximity of Er-NPCs (labelled with
Hoechst). The quantification of -Tubulin III pos-
itive cells expressing GAP43 was performed. The
graph reported in Fig. 7 shows a significant increase
in transplanted animals both rostrally and caudally
to the lesion epicenter.
3.4. Fluororuby-labeled axonal regeneration in
the injured cord
To evaluate quantitatively anterograde axonal
regeneration fluoro-ruby was injected in the rostral
cord at T6/T7 level five and twenty days after injury
(Materials & Methods section for details; Fig. 6)
(Erturk et al., 2012). Then, animals were sacrificed
five days after tracer injection. At the earliest time
point (10 days after injury and cells administration),
we observed that, while the tracer was being injected,
it quickly filled the cord and diffused rapidly away
from injection site, probably dissolved in the fluids
of the trauma-induced edema. The tracer distribu-
tion in the cord was rather homogenous and at the
lesion site, the cord was filled completely up to the
meninges (data not shown). Differently, at 25 days
post injury and Er-NPCs transplantation, fluoro-ruby
remained at site of injection with a negligible diffu-
sion and was picked up by intact axons. Thus labelling
occurred from the injection site to the caudal cord
across the lesion, this occurred both in saline and
cells-treated animals (Fig. 8). The dorsal tract label-
ing is highest at the point of injection, and then it
gradually decreases moving from the site of injection
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Fig. 4. Er-NPCs promote serotoninergic fibres sprouting through the lesion site. Serotoninergic (5-HT) fibers were investigated at the lesion
site (panel A) and 2 mm away from the lesion (panel B) 4 weeks after Er-NPCs infusion in lesioned mice. In panel A, Er-NPCs are shown
in red (PKH26) and 5-HT is shown in green. Nuclei were counterstained with DAPI (blue). In panel B, 5-HT staining is showed in red and
neuronal fibers were identified with beta-tubulin III (green). Er-NPCs were labelled with Hoechst 33342 before the infusion (blue). Scale
bars = 50 and 100m. Quantification was performed 2 mm caudally to the lesion epicenter at 10 and 30 days after Er-NPCs transplantation
in lesioned animals (panel C). The quantification was performed in spinal cord coronal sections (n = 3 for each animal; at least 6 animal per
group) as described in detail in M&M in intermediolateral and ventral horns (please see the representation). Values represent average ± SD.
We determined the statistical differences by means of an ANOVA test followed by Bonferroni’s post-test. ***p < 0.001 vs LAM; ◦p < 0.05
vs LES+PBS.
to the lesion site and it is very limited in the caudal
cord of saline-treated mice (Fig. 8 panel A). Such a
labelling is, however, much higher in the Er-NPCs
transplanted animals (Fig. 8 panel A). The highest
number of labelled axons is localized in the rostral
region of the lesion, but, as expected, they accumulate
at the injury boundaries where transplanted cells
are located. Several of these axons cross the lesion
and their number increases again just caudal to the
lesion as axons likely sprout when entering the den-
ervated caudal cord. The quantification of fluoro-ruby
labelled axons is reported in panel C of the same
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C
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Fig. 5. Er-NPCs promote chatecolaminergic fibres sprouting through the lesion site. Chatecolaminergic (TH) fibers were investigated at the
lesion site (panel A) and 2 mm caudal from the lesion (panel B) 4 weeks after Er-NPCs infusion in lesioned mice. In panel A, Er-NPCs are
shown in red and TH is shown in green. Nuclei were counterstained with DAPI (blue). In panel B, chatecolaminergic terminals are shown in
red and neuronal fibers were identified with beta-tubulin III (green). Er-NPCs were labelled with Hoechst 33342 before the infusion (blue).
Scale bars = 25m. Quantification of TH fibers quantification was performed 2 mm caudally to the lesion epicenter at 10 and 30 days after
Er-NPCs transplantation in lesioned animals. The quantification was performed in spinal cord coronal sections (n = 3 for each animal; at least
6 animals per group) as described in detail in M&M in intermediolateral and ventral horns (please see the representation). Values represent
average ± SD. We determined the statistical differences by means of an ANOVA test followed by Bonferroni’s post-test. ***p < 0.001 vs
LAM; ◦◦p < 0.01 vs LES+PBS.
figure and shows a ten-fold increase of axon labeling
in the caudal cord proximal to the lesion (1 mm) of Er-
NPCs-treated animals (Fig. 8). The labeling details in
the lesion epicenter are shown in Fig. 9. The higher
axonal labeling observed in the rostral regions sug-
gests a powerful axonal regeneration promoted by
Er-NPCs localized at the injury site (Figs. 8 and 9).
4. Discussion
The results described in this study extend pre-
vious observations on the reparatory properties of
Er-NPCs when applied in spinal cord injury (Carelli
et al., 2014b; Carelli et al., 2015). We had reported
that i.v. applied Er-NPCs accumulate, survive and
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Fig. 6. Myelin preservation in the injured cord of animals treated with Er-NPCs. Myelin preservation was evaluated by means of
Fluoromyelin™ staining (green) performed in sections at the lesion epicenter, and 2 mm caudally to the lesion site (please see schematic
representation).
Table 3
Er-NPCs treatment preserves myelin in the injured cord. Myelin preservation was evaluated by means of Fluoromyelin™ staining (green)
performed in sections at the lesion epicenter, and 2 mm caudally to the lesion site (please see Supplementary Figure 2). Quantification
was performed by confocal analysis of ventral and lateral white matter sections taken as indicated in the graphs. For the quantification, we
considered sections (n = 3) from three animals per group. Values represent average ± SD. We determined the statistical differences by means
of ANOVA test followed by Tukey’s post-test
Lesion site 2mm caudal
vWM iWM vWM iWM
LAM 1.023 ± 0.051 1.043 ± 0.048 1.036 ± 0.236 1.032 ± 0.235
LES+PBS 0.068 ± 0.032 0.495 ± 0.086 0.586 ± 0.041 0.505 ± 0.042
(p < 0.01 vs LAM) (p < 0.01 vs LAM) (p < 0.01 vs LAM) (p < 0.01 vs LAM;
p < 0.05 vs PBS)
LES+Er-NPCs 0.885 ± 0.251 0.797 ± 0.201 0.737 ± 0.075 0.664 ± 0.068
(p < 0.05 vs PBS) (p < 0.05 vs PBS) (p < 0.01 vs LAM) (p < 0.01 vs LAM)
differentiate at injury site and improve recovery of
function through the reduction of post-traumatic neu-
roinflammation (Carelli et al., 2014a; Carelli et al.,
2014b; Carelli et al., 2015). Er-NPCs localize at the
edges of injury where the microenvironment might be
positively affected by the powerful counteraction of
reactive inflammation (Carelli et al., 2014b; Carelli
et al., 2015). This is accompanied by the significant
preservation of lesion site spinal cord parenchyma
and significantly attenuated myelin loss in the ven-
tral and medioventral pathways. Here it is shown
that such an improvement of the injury site may
have changed the cord local microenvironment now
capable of sustaining axonal regeneration across the
injury as demonstrated by red ruby axonal labelling.
This is also specifically true for descending 5-HT
and catecholamine containing fibers that markedly
re-innervate the caudal cord. GAP-43 expression
is often correlated with axon re-growth potential
(Aigner et al., 1995; Benowitz and Routtemberg,
1997; Chaisuksunt et al., 2000; Donnelly et al., 2013),
and its higher expression in the caudal cord sup-
ports the enhanced regeneration across the lesion in
Er-NPCs transplanted mice.
We previously reported that Er-NPCs release ery-
thropoietin (Marfia et al., 2011), and their intrastriatal
injection promoted recovery of function in a model
of Parkinson’s disease through erythropoietin release
(Carelli et al., 2016; Carelli et al., 2017). After
i.v. infusion Er-NPCs were able to counteract the
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Fig. 7. GAP43 expression in Er-NPCS transplanted cord. Qualitative picture of GAP43 expression investigated 2 mm away (rostral and
caudal) from the cord lesion site of lesioned animals transplanted with Er-NPCs and PBS. GAP 43 is showed in red and neuronal fibres were
detected with beta-tubulin III staining (green). In order to perform double staining in these experiments Er-NPCs were labelled with Hoechst
33342 (blue). Scale bars = 75m. Pictures are representative of at least three different immunostaining experiments. The fluorescence
intensity of GAP 43 is showed in the graph (below) and was performed in three animals per group. Statistical significance was determined by
ANOVA test followed by Bonferroni’s post-test. ***p < 0.001 vs Les+Er-NPCs; ◦◦◦p < 0.001 vs Les+PBS rostral; $$$p < 0.001 vs Les+PBS
caudal.
secondary degeneration process by inhibiting the
expression of pro-inflammatory cytokines (Carelli
et al., 2014b; Carelli et al., 2015). Here, we show that
the neuroprotective action of transplanted Er-NPCs
allowed the structural preservation or neo-formation
of a favorable milieu, this is suggested by the higher
preservation of neuronal markers such as -tubulin
III and MAP-2 at the lesion site. This is in agreement
with previously reported reduction of the lesion size
by Er-NPCs administration as shown by quantitative
morphology and in vivo NMR (Carelli et al., 2015).
Our lesioning paradigm does not completely severe
the cord, and in addition to the lateral and ventral path-
ways there are channels of survived spinal tissue, but
the post-traumatic inflammation and hypoxia renders
these portions quite hostile for axonal regrowth. It is,
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A
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Fig. 8. In vivo axonal transport recovery in spinal cord of animal transplanted or not with Er-NPCs. Panel A. Qualitative image of anterograde
axonal transport at 25 days after lesion in PM-NPC treated animals. As described in material and methods section fluororuby was injected at
T6/T7 at day 20 after lesioning and animal sacrificed five days later. Schematic reconstruction of spinal cord longitudinal sections of lesioned
(below) and lesioned+Er-NPCs (above) treated animals. Er-NPCs were stained with Hoechst (blue). Panel B. Quantification of fluorescence
2 cm, 1 cm and 1 mm away from the lesion. Sections were taken from animals transplanted or not with Er-NPCs. Quantification was
performed in three animals per group 25 days after lesion. We determined the statistical differences by means of an ANOVA test followed by
Bonferroni’s post-test. **p < 0.01, ***p < 0.001 vs saline treatment; ◦◦p < 0.01 vs 2 cm transplanted mice; ###p < 0.001 vs 1 cm transplanted
mice.
thus, conceivable that the prompt effect of Er-NPCs
renders these territories amenable to sustain axonal
regrowth as we report here. This is likely the biolog-
ical base for the highly more trophic cord observed
even 10 months after lesioning and transplantation by
NMR (Carelli et al., 2015).
Perrin and coworkers transplanted lentiviral trans-
duced human embryonic neural progenitors capable
of expressing neurogenin-2 (Perrin et al., 2011) and
reported that animal functional recovery correlated
with partial restoration of serotonin fiber density
caudal to the lesion (Perrin et al., 2011). In addi-
tion, immature astrocytes derived from bone marrow
stromal cells grafted into the injured spinal cord
were able to promote the outgrowth of 5HT-positive
fibers since they offered a growth-permissive surface
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Fig. 9. Detail of anterograde axonal labelling relative to Er-NPCs transplanted animals (at 30 days). The reconstruction is referring to
longitudinal sections of lesion site epicenter (T9) and 1 mm away from the lesion. Scale bars = 100m.
(Hofstetter et al., 2005). The positive effectiveness of
stem cells transplants in the injured CNS might be
due to the release of trophic factors by the engrafted
cells (Martino & Pluchino, 2006; McTigue et al.,
1998; Widenfalk et al., 2001; De Lima et al., 2012).
The present study reports that TH-positive fiber den-
sity in the ventral portion of the lumbosacral cord
of lesioned Er-NPCs treated mice is much higher
than in saline-treated lesioned mice. Interestingly,
these evidences are in accordance with what has
been reported previously in spinal cord lesioned rats
acutely treated with rhEPO (Cerri et al., 2012). Here
it was reported that exogenous administration of
rhEPO increased the preservation of TH – positive
fibers and buttons in the lesioned cord and this cor-
responded to larger descending spinal and ascending
cortical evoked potentials (Cerri et al., 2012). Plas-
ticity and its adaptive changes following injury are
among the most studied problems in neuroscience,
and there is much evidence that the serotonin and
noradrenaline systems are involved in the suble-
sional changes following traumatic lesions to the cord
(Parker, 2000; Jordan et al., 2008; Harkema et al.,
2011).
An ideal treatment capable of inducing axon regen-
eration in the injured central spinal cord should
attenuate scarring (Abematsu et al., 2006), the pro-
duction of growth-inhibitory factors at the lesion site
(Ballerman & Fouad, 2006; Cao et al., 2002) and,
at the same time, stimulate axon growth (Tran et al.,
2015; Williams et al., 2015; Young, 2015). Er-NPCs
could improve the recovery of function and favour
axon regeneration likely by supplying a favorable
environment and releasing EPO that has powerful
anti-inflammatory activity by reducing the expres-
sion of inflammatory cytokines and counteracting the
invasion by inflammatory cells into the injury site
(Gorio et al., 2002; Gorio et al., 2005). This results
in the attenuation of secondary degeneration. This
results in the enhancement of spared tissue at the
injury site with particular protective effects on the
reticulospinal tract leading to behavioral recovery.
Transplanted Er-NPCs have a higher survival capabil-
ity in such an unfavorable environment compared to
regular adult NSCs. We had previously reported that
i.v. infused adult neural stem cells (NSCs), isolated
from the subventricular zone (SVZ), are able to reach
the injury site and improve the early rate of hindlimb
functional recovery, but they are vital for a couple
of weeks since at 3 weeks they are phagocytized by
macrophages and the process of recovery stops (Bot-
tai et al., 2008). Thus, the effects of Er-NPCs might be
a combination of anti-inflammatory and neuroprotec-
tive actions that finally result in spinal tissue sparing
(Gorio et al., 2002; Gorio et al., 2005) with the supple-
mentation of a positive microenvironment that might
be of a key importance in allowing axonal regenera-
tion across the lesion. Further studies are required to
elucidate the mechanisms underlying Epo–mediated
reduction of the inhibitory properties of the glial
scar. In our previous work, we reported that intra-
venously infused Er-NPCs reach the lesion site where
they modify the local microenvironment by reduc-
ing the production of pro-inflammatory cytokines
(Carelli et al., 2015) and the infiltration of inflam-
matory cells, such as macrophages and neutrophils,
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which contribute greatly to secondary degenera-
tion (Carelli et al., 2014b; Carelli et al., 2015).
Moreover, the local production of growth factors such
as BDNF and NGF is increased (Carelli et al., 2015),
and this might stimulate neuronal survival and axonal
regrowth (Lindsay, 1998; Zhang et al., 2000; Li et al.,
2015). Recently it has been reported that embryonic
NSCs transplantation in aged mice is able to enhance
functional recovery from spinal cord injury by mod-
ification of cord microenvironement by inducing the
local expression of growth factors, especially HGF
(Takano et al., 2017). We also reported recently that
the administration of Er-NPCs in a mouse experimen-
tal model of Parkinson’s disease promoted both the
recovery of function and restoration of TH positive
neurons in the substantia nigra (Carelli et al., 2016;
Carelli et al., 2017). These curative effects were due
to the physiologic release of erythropoietin as the co-
injection of the specific inhibitory antibody abrogated
the effect of transplanted cells (Carelli et al., 2016;
Carelli et al., 2017).
Many evidences show that stem cells implants by
themselves are not able to stimulate significant num-
bers of axons to exit the injury site, and provide only
modest improvements in functional outcome (Fitch
et al., 2008; De Lima et al., 2012). For these rea-
sons, in order to mediate significant anatomical repair
and/or functional improvements, the effects of stem
cell implants have been increased with various phar-
macological, molecular, or biomaterial approaches
that overcome intrinsic or extrinsic inhibitors of axon
growth, such as neurotrophin supplementation, chon-
droitinase ABC, polysialic acid, matrix suspension,
or cyclic AMP elevation (Fawcett et al., 2006; Pearse
et al., 2004; Iorgulescu et al., 2015; Takami et al.,
2002; Flora et al., 2013). Differently, the present
report provides new insights into the effects of trans-
planted adult neural precursors that likely via local
physiologic release of EPO, promote neural tissue
sparing and axonal regeneration leading to a sig-
nificant recovery of function. We also suggest that
Er-NPCs, and cells with similar properties, may
represent good candidates for cellular therapy in neu-
rodegenerative disorders.
5. Conclusions
This study shows that Er-NPCs promoted recovery
of function after spinal cord injury, accompanied by
preservation of myelination and strong re-innervation
of the distal cord.
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